Immunohistochemical and metabolomic analysis of Tibetan medicine triphala in response to pancreatic tissues of diabetic rats
Abstract
Tibetan Medicine Triphala (THL), consisting of Emblica officinalis, Terminalia bellerica, and Terminalia chebula, is a traditional Tibetan remedy for diabetes mellitus (DM). This study investigated THL's pancreatic metabolomic effects and impacts on paracrine factors (glucagon, insulin, somatostatin, pancreatic polypeptide) in diabetic rats. Rats were divided into six groups, gavaged for 8 weeks, with weekly blood glucose/body weight monitoring. THL reduced serum glucagon, somatostatin, pancreatic polypeptide, elevated insulin, restored pancreatic β-cell function, downregulated α/δ/pp cell expressions, normalized 5 key differential metabolites, and modulated four core metabolic pathways, exerting antidiabetic effects.
Fields of Study & Subjects
Phytochemicals and Medicinal Plants
Natural Antidiabetic Agents Studies
Medicinal Plants and Neuroprotection
Publication details
- Journal / source
- Journal of Asian Natural Products Research
- Volume
- 28
- Issue
- 10
- Pages
- 1495–1513
- Publication date
- 6 January 2026
- Language
- EN